CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $88.51 -1.93%
EPS Growth %: +3.1%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
LTBR, AES, SYRS, More
EPS Growth %: +3.1%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.21, $0.08 better than the analyst estimate of $2.13. Revenue for the quarter came in at $88.92 billion versus the consensus estimate of $86.41 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.50-$8.70, versus the consensus of $8.59.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- ONE Gas (OGS) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Ero Copper Corp. (ERO) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
